Moderna’s cancer shot: exciting for investors, inconclusive for patients
A glimmer of hope for sufferers, a potential revenue platform for a cash-burner, and a whole heap of unknowns
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.ft.com — the content belongs to Financial Times.
